HIGHLIGHTS
- who: MRSA and collaborators from the Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA have published the article: Clearance during Super-Infection, in the Journal: (JOURNAL) of December/31,/2015
- what: The authors examined the role of rosiglitazone treatment during influenza infection and influenza-bacterial super-infection by determining influenza viral burden, viral-induced interferons and their downstream stimulated genes, inflammatory cellular responses, and pro- and anti-inflammatory cytokines in the lung. The study has shown that rosiglitazone treatment decreased the levels of IL-6, IL-12, CCL-2 and CCL6 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.